340 related articles for article (PubMed ID: 38279176)
21. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma
Xiao Q; Liu H; Wang HS; Cao MT; Meng XJ; Xiang YL; Zhang YQ; Shu F; Zhang QG; Shan H; Jiang GM
Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
[TBL] [Abstract][Full Text] [Related]
23. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma.
Wu YJ; Ko BS; Liang SM; Lu YJ; Jan YJ; Jiang SS; Shyue SK; Chen L; Liou JY
Cell Death Dis; 2019 May; 10(6):408. PubMed ID: 31138789
[TBL] [Abstract][Full Text] [Related]
24. EB2 promotes hepatocellular carcinoma proliferation and metastasis via MAPK/ERK pathway by modulating microtubule dynamics.
Zhong FJ; Li YM; Xu C; Sun B; Wang JL; Yang LY
Clin Sci (Lond); 2021 Apr; 135(7):847-864. PubMed ID: 33755094
[TBL] [Abstract][Full Text] [Related]
25. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
27. NF45 promotes esophageal squamous carcinoma cell invasion by increasing Rac1 activity through 14-3-3ε protein.
Wen-Jian Y; Song T; Jun T; Kai-Ying X; Jian-Jun W; Si-Hua W
Arch Biochem Biophys; 2019 Mar; 663():101-108. PubMed ID: 30550728
[TBL] [Abstract][Full Text] [Related]
28. The Role of Autophagy in Hepatocellular Carcinoma.
Lee YJ; Jang BK
Int J Mol Sci; 2015 Nov; 16(11):26629-43. PubMed ID: 26561802
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
[TBL] [Abstract][Full Text] [Related]
30. Role of the Chaperone Protein 14-3-3ε in the Regulation of Influenza A Virus-Activated Beta Interferon.
Tam EH; Liu YC; Woung CH; Liu HM; Wu GH; Wu CC; Kuo RL
J Virol; 2021 Sep; 95(20):e0023121. PubMed ID: 34379499
[TBL] [Abstract][Full Text] [Related]
31. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma.
Ou Y; He J; Liu Y
IUBMB Life; 2018 Jun; 70(6):468-478. PubMed ID: 29676845
[TBL] [Abstract][Full Text] [Related]
32. Nucleo-cytoplasmic shuttling of 14-3-3 epsilon carrying hnRNP C promotes autophagy.
Guo M; He M; Zhang Y; Liu W; Qi M; Liu Z; Yi G; Deng S; Li Y; Sun X; Zhao L; Chen T; Liu Y
Cancer Biol Ther; 2023 Dec; 24(1):2246203. PubMed ID: 37599448
[TBL] [Abstract][Full Text] [Related]
33. The role of HSP90 molecular chaperones in hepatocellular carcinoma.
Nouri-Vaskeh M; Alizadeh L; Hajiasgharzadeh K; Mokhtarzadeh A; Halimi M; Baradaran B
J Cell Physiol; 2020 Dec; 235(12):9110-9120. PubMed ID: 32452023
[TBL] [Abstract][Full Text] [Related]
34. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
[TBL] [Abstract][Full Text] [Related]
35. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line.
Huo S; Yu H; Li C; Zhang J; Liu T
Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857
[TBL] [Abstract][Full Text] [Related]
36. Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma.
Kamayirese S; Maity S; Dieckman LM; Hansen LA; Lovas S
bioRxiv; 2023 Oct; ():. PubMed ID: 37873379
[TBL] [Abstract][Full Text] [Related]
37. FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801.
Yamaguchi F; Hirata Y; Akram H; Kamitori K; Dong Y; Sui L; Tokuda M
BMC Cancer; 2013 Oct; 13():468. PubMed ID: 24112473
[TBL] [Abstract][Full Text] [Related]
38. BACH1 is transcriptionally inhibited by TET1 in hepatocellular carcinoma in a microRNA-34a-dependent manner to regulate autophagy and inflammation.
Sun X; Zhu H; Cao R; Zhang J; Wang X
Pharmacol Res; 2021 Jul; 169():105611. PubMed ID: 33878446
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
Liu F; He Y; Shu R; Wang S
Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
